Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Explore

Analyst Notes

Stocks – Q : Quality | V : Valuation | PT : Price Trend
Funds – P : Performance | Q : Quality

Top Pharma Companies in India by Market Cap

BSE Sensex 77844.52
114 (-0.15%)

Top Pharma Companies in India as on May-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Rainbow Childrens Medicare Ltd.	Q V PT	13,045 Small Cap	1,292.15 (0.60%)	53.19	7.91	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Astrazeneca Pharma India Ltd.	Q V+ PT	20,924 Small Cap	8,535.30 (1.98%)	104.15	25.16	15.59	20.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Fortis Healthcare Ltd.	Q V+ PT	72,283 Mid Cap	947.50 (-1.04%)	443.08	7.85	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Vijaya Diagnostic Centre Ltd.	Q V PT	11,500 Small Cap	1,208.85 (1.64%)	72.13	12.67	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Themis Medicare Ltd.	Q V PT	916 Small Cap	98.81 (-0.69%)	N/A	3.06	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Mankind Pharma Ltd.	Q V PT	97,506 Mid Cap	2,375.40 (0.57%)	57.24	6.11	14.65	12.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Morepen Laboratories Ltd.	Q V+ PT	2,387 Small Cap	44.04 (1.10%)	41.26	1.96	14.44	19.03	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Laurus Labs Ltd.	Q V+ PT	63,517 Mid Cap	1,206.45 (2.54%)	71.46	11.98	14.42	4.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Neuland Laboratories Ltd.	Q V+ PT	21,775 Small Cap	17,300.45 (1.94%)	122.11	13.18	14.13	64.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Kovai Medical Center & Hospital Ltd.	Q V+ PT	6,253 Small Cap	5,757.45 (0.76%)	26.52	4.98	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	GPT Healthcare Ltd.	Q V PT	1,154 Small Cap	142.15 (1.10%)	28.46	4.38	13.96	24.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Unichem Laboratories Ltd.	Q V PT	2,726 Small Cap	391.95 (1.24%)	12.08	1.03	13.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Orchid Pharma Ltd.	Q V PT	3,363 Small Cap	681.40 (2.76%)	79.22	2.51	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Vimta Labs Ltd.	Q V+ PT	2,282 Small Cap	505.25 (-1.10%)	29.44	5.26	13.74	62.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	SMS Pharmaceuticals Ltd.	Q V+ PT	3,879 Small Cap	420.60 (1.55%)	44.43	4.95	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Dr. Reddys Laboratories Ltd.	Q V PT	1,09,382 Mid Cap	1,306.80 (-0.28%)	19.64	2.94	13.26	22.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Shree Ganesh Remedies Ltd.	Q V PT	621 Small Cap	488.35 (1.03%)	34.28	3.96	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Healthcare Global Enterprises Ltd.	Q V+ PT	9,266 Small Cap	615.10 (-0.89%)	399.38	5.76	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Dr. Lal Pathlabs Ltd.	Q V PT	26,598 Small Cap	1,566.65 (-1.26%)	52.34	10.76	13.05	17.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Emcure Pharmaceuticals Ltd.	Q V PT	31,472 Small Cap	1,662.90 (0.17%)	42.94	8.48	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Shalby Ltd.	Q V PT	1,796 Small Cap	167.45 (0.69%)	24.21	1.5	12.52	25.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Ajanta Pharma Ltd.	Q V PT	38,646 Small Cap	3,080.20 (-0.42%)	36.6	8.54	12.43	17.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Tarsons Products Ltd.	Q V+ PT	1,214 Small Cap	228.35 (0.11%)	36.87	1.81	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	8,696 Small Cap	548.30 (-0.76%)	70.11	3.62	12.22	23.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Gujarat Themis Biosyn Ltd.	Q V+ PT	4,125 Small Cap	398.50 (5.26%)	86.33	14.9	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Narayana Hrudayalaya Ltd.	Q V+ PT	37,598 Mid Cap	1,862.10 (1.21%)	48.27	8.97	11.88	45.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Krishna Institute of Medical Sciences Ltd	Q V PT	28,050 Small Cap	707.55 (0.93%)	97.29	11.87	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	RPG Life Sciences Ltd.	Q V+ PT	3,946 Small Cap	2,480.95 (3.98%)	34.27	6.52	11.71	30.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Divis Laboratories Ltd.	Q V+ PT	1,78,026 Large Cap	6,700.75 (-0.08%)	71.81	11.13	11.65	10.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,407 Small Cap	213.35 (1.84%)	32.65	5.09	11.13	39.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Company Name	CMP	Price Change(%)
Piramal Pharma	183.85	11.36%
Indoco Remedies	251.25	10.22%
Nectar Lifesciences	13.59	9.95%
Sun Pharma Adv. Res	166.95	6.30%
Guj. Kidney & Super	130.90	6.03%

Company Name	CMP	Price Change(%)
Wockhardt	1,636.75	-4.85%
Rubicon Research	951.90	-4.72%
Wanbury	252	-2.25%
Concord Biotech	1,197.15	-2.12%
Aarti Pharmalabs	776.60	-1.51%

News about Top Pharma Companies in India

May, 2026

Vimta Labs - Quaterly Results

The revenue zoomed 15.68% to Rs. 1092.45 millions for the quarter ended March 2026 as compared to Rs. 944.41 millions during the corresponding quarter last year.A humble growth in net profit of 15.25% reported in the quarter ended March 2026 to Rs. 211.13 millions from Rs. 183.19 millions.Operating profit for the quarter ended March 2026 rose to 421.19 millions as compared to 346.77 millions of corresponding quarter ended March 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	1092.45	944.41	15.68	4072.90	3439.82	18.40	4072.90	3439.82	18.40
Other Income	27.51	16.40	67.74	89.89	42.40	112.00	89.89	42.40	112.00
PBIDT	421.19	346.77	21.46	1505.08	1261.89	19.27	1505.08	1261.89	19.27
Interest	3.21	4.38	-26.71	11.67	19.00	-38.58	11.67	19.00	-38.58
PBDT	417.98	342.39	22.08	1477.25	1242.89	18.86	1477.25	1242.89	18.86
Depreciation	127.51	92.12	38.42	437.72	352.89	24.04	437.72	352.89	24.04
PBT	290.47	250.27	16.06	1039.53	890.00	16.80	1039.53	890.00	16.80
TAX	79.34	67.08	18.28	264.41	222.45	18.86	264.41	222.45	18.86
Deferred Tax	16.91	-2.58	-755.43	-1.07	12.66	-108.45	-1.07	12.66	-108.45
PAT	211.13	183.19	15.25	775.12	667.55	16.11	775.12	667.55	16.11
Equity	89.34	44.47	100.90	89.34	44.47	100.90	89.34	44.47	100.90
PBIDTM(%)	38.55	36.72	5.00	36.95	36.68	0.73	36.95	36.68	0.73

May, 2026

Ajanta Pharma - Quaterly Results

The Revenue for the quarter ended March 2026 of Rs. 12105.30 millions grew by 19.39 % from Rs. 10139.40 millions.Net profit showed a marginal rise at Rs. 1972.80 millions for the quarter ended March 2026, as compared to corresponding quarter of last year.Operating profit surged to 3010.30 millions from the corresponding previous quarter of 2675.80 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	12105.30	10139.40	19.39	48459.20	43220.40	12.12	48459.20	43220.40	12.12
Other Income	629.80	179.30	251.25	2044.00	1198.70	70.52	2044.00	1198.70	70.52
PBIDT	3010.30	2675.80	12.50	14023.90	13245.90	5.87	14023.90	13245.90	5.87
Interest	-7.40	6.70	-210.45	25.90	46.00	-43.70	25.90	46.00	-43.70
PBDT	3017.70	2669.10	13.06	13998.00	13199.90	6.05	13998.00	13199.90	6.05
Depreciation	441.60	387.60	13.93	1687.70	1399.30	20.61	1687.70	1399.30	20.61
PBT	2576.10	2281.50	12.91	12310.30	11800.60	4.32	12310.30	11800.60	4.32
TAX	603.30	347.20	73.76	2842.10	2631.70	7.99	2842.10	2631.70	7.99
Deferred Tax	-70.00	-43.80	59.82	76.00	51.40	47.86	76.00	51.40	47.86
PAT	1972.80	1934.30	1.99	9468.20	9168.90	3.26	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	24.87	26.39	-5.77	28.94	30.65	-5.57	28.94	30.65	-5.57

May, 2026

Emcure Pharma - Quaterly Results

A fair growth of 14.83% in the revenue at Rs. 14677.03 millions was reported in the March 2026 quarter as compared to Rs. 12781.88 millions during year-ago period.Net profit surges 67.46% to Rs. 2336.97 millions from Rs. 1395.57 millions in the quarter ended March 2026.The company reported a good operating profit of 3985.94 millions compared to 2670.33 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	14677.03	12781.88	14.83	52431.88	43819.24	19.65	52431.88	43819.24	19.65
Other Income	269.39	223.96	20.28	2095.16	1188.07	76.35	2095.16	1188.07	76.35
PBIDT	3985.94	2670.33	49.27	13342.66	7656.44	74.27	13342.66	7656.44	74.27
Interest	368.67	240.69	53.17	1182.71	1129.62	4.70	1182.71	1129.62	4.70
PBDT	3693.06	2429.64	52.00	11909.24	6526.82	82.47	11909.24	6526.82	82.47
Depreciation	630.40	569.12	10.77	2467.33	2249.72	9.67	2467.33	2249.72	9.67
PBT	3062.66	1860.52	64.61	9441.91	4277.10	120.75	9441.91	4277.10	120.75
TAX	725.69	464.95	56.08	2112.32	1105.82	91.02	2112.32	1105.82	91.02
Deferred Tax	-62.93	-170.95	-63.19	-225.09	-21.25	959.25	-225.09	-21.25	959.25
PAT	2336.97	1395.57	67.46	7329.59	3171.28	131.12	7329.59	3171.28	131.12
Equity	1895.90	1894.83	0.06	1895.90	1894.83	0.06	1895.90	1894.83	0.06
PBIDTM(%)	27.16	20.89	29.99	25.45	17.47	45.64	25.45	17.47	45.64

May, 2026

Emcure Pharmaceuticals informs about change in management

Pursuant to Regulation 30 of the SEBI Listing Regulations and based on the recommendation of the Nomination and Remuneration Committee, Emcure Pharmaceuticals has informed that the Board of Directors of the Company at their meeting held today i.e. Tuesday, May 05, 2026, has approved the re-appointment of the following Directors, subject to approval of shareholders: 1. Dr. Mukund Gurjar (DIN: 00026843) as a Whole-time Director of the Company for a further period of 1 (One) year commencing from August 28, 2026; 2. Satish Mehta (DIN: 00118691) as the Managing Director of the Company, for a further period of 5 (Five) years with effective from April 01, 2027. Dr. Mukund Gurjar and Satish Mehta are not debarred from holding the office of a Director by virtue of any Securities and Exchange Board of India (‘SEBI’) SEBI order and in accordance with BSE Circular No. LIST/COMP/14/2018-19 dated June 20, 2018 and NSE Circular No. NSE/CML/2018/02 dated June 20, 2018, or any such other authority, and that they are not related to any Director(s) or Key Managerial Personnel(s) of the Company. The particulars of the disclosure required under Regulation 30 and Part A of Schedule III of the SEBI Listing Regulations are enclosed. The meeting of the Board of Directors of the Company commenced at 12.42 pm (IST) and concluded at 2.00 pm (IST).

The above information is a part of company’s filings submitted to BSE.

May, 2026

Rainbow Children's Medicare informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), Rainbow Children's Medicare has informed that the Company has inaugurated the following new healthcare facilities: 1. A new 60 beds Spoke Hospital, located at HRBR Layout, Hennur Junction, Karnataka; and 2. An IVF Centre under the brand name BirthRight Fertility, an extension of Marathahalli hub located at Mahadevpura, Karnataka. The requisite disclosures as required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as Annexure - A - Disclosure relating to the Spoke Hospital at HRBR layout, Hennur Junction & the IVF Centre, BirthRight Fertility, Mahadevpura. Further, a press release in connection with the inauguration of the above facilities is enclosed as Annexure - B.

The above information is a part of company’s filings submitted to BSE.

May, 2026

SMS Pharmaceuticals informs about newspaper publication

SMS Pharmaceuticals has enclosed copies of the newspaper advertisements published today in the the Financial Express (English), and in Nava Telangana (Telugu), informing about the Investor Education and Protection Fund Authority’s (IEPFA) ‘Second 100-Days CampaignSaksham Niveshak’. This information is also being uploaded on the Company’s website at www.smspharma.com

The above information is a part of company’s filings submitted to BSE.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Health X Platform Ltd.	907 Crore
2	Fischer Medical Ventures Ltd.	2,506 Crore
3	3B Blackbio Dx Ltd.	1,129 Crore
4	Max Healthcare Institute Ltd.	98,852 Crore
5	Indegene Ltd.	12,835 Crore
6	Acutaas Chemicals Ltd.	21,963 Crore
7	Rubicon Research Ltd.	16,494 Crore
8	Yatharth Hospital & Trauma Care Services Ltd.	7,923 Crore
9	Dr. Agarwals Health Care Ltd.	14,521 Crore
10	Sigachi Industries Ltd.	765 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,692	55,876	36.66	12.74	25.65	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,359	1,47,478	64.91	16.23	36.68	26.68
Ajanta Pharma Ltd. (S)	Very Good	3,080	38,646	36.60	8.54	24.73	24.45
Lupin Ltd. (M)	Somewhat Good	2,460	1,11,668	24.04	5.37	14.31	20.83
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,206	63,517	92.14
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,371	66,987	68.93
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,141	34,370	42.38
Wockhardt Ltd. (S)	Not Good	1,637	27,953	39.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,359	1,47,478	33.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,141	34,370	47.25	8.81	29.84	17.81
Mankind Pharma Ltd. (M)	Very Good	2,375	97,506	57.24	6.11	34.36	14.65
Laurus Labs Ltd. (M)	Very Good	1,206	63,517	71.46	11.98	35.90	14.42
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	13.26
Ajanta Pharma Ltd. (S)	Very Good	3,080	38,646	36.60	8.54	24.73	12.43

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	30.57
Cipla Ltd. (L)	Very Good	1,363	1,10,283	24.26	3.28	14.63	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,834	4,43,973	40.67	5.47	22.24	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	22.29
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,141	34,370	47.25	8.81	29.84	19.45

About MoneyWorks4Me

*Color code for outperformance consistency

*Number is average 3 year rolling returns

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Vimta Labs - Quaterly Results

Ajanta Pharma - Quaterly Results

Emcure Pharma - Quaterly Results

Emcure Pharmaceuticals informs about change in management

Rainbow Children's Medicare informs about updates

SMS Pharmaceuticals informs about newspaper publication

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Vimta Labs - Quaterly Results

Ajanta Pharma - Quaterly Results

Emcure Pharma - Quaterly Results

Emcure Pharmaceuticals informs about change in management

Rainbow Children's Medicare informs about updates

SMS Pharmaceuticals informs about newspaper publication

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.